ATRC News and Press, AtriCure Inc.

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Citizens Life Sciences...

2026-02-17 19:25:37 ET More on AtriCure AtriCure, Inc. (ATRC) Q4 2025 Earnings Call Transcript AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference ...

2026-02-17 19:24:57 ET AtriCure, Inc. (ATRC) Q4 2025 Earnings Call February 17, 2026 4:30 PM EST Company Participants Michael H. Carrel - CEO, President & Director Angela Wirick - Chief Financial Officer ... Read the full article on Seeking Alpha For ...

2026-02-17 18:19:31 ET Image source: The Motley Fool. Tuesday, Feb. 17, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-17 16:03:32 ET More on AtriCure AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AtriCure slides 15% after JPMorgan downgrade...

Fourth Quarter 2025 worldwide revenue of $140.5 million – an increase of 13.1% year over year Fourth Quarter 2025 net income of $1.8 million and positive adjusted EBITDA of $19.9 million Full Year 2025 worldwide revenue of $534.5 million – an increase of 14.9% year over year...

Iamgold Corporation (IAG) is expected to report $0.55 for Q4 2025 Bel Fuse Inc (BELFB) is expected to report $1.44 for Q4 2025 Beta Bionics Inc. (BBNX) is expected to report $-0.42 for Q4 2025 TPG RE Finance Trust Inc. (TRTX) is expected to report $0.25 for Q4 2025 CEVA Inc. (CEVA...

2026-02-11 12:40:36 ET More on AtriCure AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow AtriCure, Inc. (ATRC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript Seeking Alpha’s Quant Rating on AtriC...

AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release its fourth quarter and full year 2025 financial results ...

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) --   Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through 2034 [1] . This systemic re-rating is driven by healthcare’s structural pivot fr...